Worth Venture Partners, LLC Ardelyx, Inc. Transaction History

Worth Venture Partners, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.59 - $1.44 $335,029 - $817,699	-567,847 Reduced 60.93%	364,102 $433,000
Q2 2022 Aug 15, 2022	BUY	$0.51 - $1.17 $83,595 - $191,778	163,913 Added 21.34%	931,949 $649,000
Q1 2022 May 16, 2022	BUY	$0.65 - $1.18 $141,089 - $256,131	217,061 Added 39.4%	768,036 $822,000
Q4 2021 Feb 14, 2022	BUY	$0.86 - $1.7 $473,838 - $936,657	550,975 New	550,975 $606,000

218

141M

1.08M

Ticker ARDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 154,636,000
Market Cap $799M
Description
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...

Get notified when there are updates to the investment portfolio of Worth Venture Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Worth Venture Partners, LLC with notifications on news.